Handelsbanken Fonder
WST icon

Handelsbanken Fonder’s West Pharmaceutical WST Stock Holding History

Handelsbanken Fonder’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7M Sell
49,193
-8,535
-15% -$2.61M 0.05% 293
2026
Q1 		$14.5M Sell
57,728
-5,526
-9% -$1.37M 0.05% 300
2025
Q4 		$17.4M Buy
63,254
+2,474
+4% +$677K 0.05% 285
2025
Q3 		$15.9M Buy
60,780
+858
+1% +$209K 0.05% 300
2025
Q2 		$13.1M Buy
59,922
+8,354
+16% +$1.79M 0.05% 316
2025
Q1 		$11.5M Sell
51,568
-4,111
-7% -$1.13M 0.05% 316
2024
Q4 		$18.2M Buy
55,679
+4,940
+10% +$1.55M 0.07% 262
2024
Q3 		$15.2M Sell
50,739
-31
-0.1% -$9.49K 0.06% 280
2024
Q2 		$16.7M Buy
50,770
+8,662
+21% +$3.06M 0.07% 239
2024
Q1 		$16.7M Buy
42,108
+2,258
+6% +$835K 0.07% 250
2023
Q4 		$14M Sell
39,850
-10,805
-21% -$3.82M 0.07% 272
2023
Q3 		$19M Buy
50,655
+158
+0.3% +$61.1K 0.11% 198
2023
Q2 		$19.3M Buy
50,497
+1,855
+4% +$663K 0.1% 216
2023
Q1 		$16.9M Buy
48,642
+3,314
+7% +$968K 0.1% 236
2022
Q4 		$10.7M Buy
45,328
+25,073
+124% +$5.94M 0.07% 296
2022
Q3 		$4.98M Buy
20,255
+600
+3% +$183K 0.03% 416
2022
Q2 		$5.94M Buy
19,655
+1,300
+7% +$423K 0.04% 397
2022
Q1 		$7.54M Sell
18,355
-595
-3% -$233K 0.04% 385
2021
Q4 		$8.89M Sell
18,950
-878
-4% -$378K 0.04% 369
2021
Q3 		$8.42M Hold
19,828
– – 0.04% 376
2021
Q2 		$7.12M Buy
19,828
+2,000
+11% +$661K 0.04% 417
2021
Q1 		$5.02M Buy
17,828
+398
+2% +$114K 0.03% 433
2020
Q4 		$4.94M Buy
17,430
+4,135
+31% +$1.16M 0.03% 411
2020
Q3 		$3.65M Hold
13,295
– – 0.03% 426
2020
Q2 		$3.02M Buy
+13,295
New +$2.61M 0.03% 437

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Handelsbanken Fonder's WST Position: Q2 2026 in Review

Handelsbanken Fonder reduced its West Pharmaceutical (WST) stake by 15% in Q2 2026, selling an estimated $2.61M and leaving 49,193 shares worth $17.7M. The position accounts for 0.05% of the portfolio, ranked #293.

Handelsbanken Fonder first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $19.3M in Q2 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Handelsbanken Fonder held 49,193 shares of West Pharmaceutical worth $17.7M as of Q2 2026.
  • Handelsbanken Fonder sold 8,535 West Pharmaceutical shares in Q2 2026, an estimated $2.61M.
  • West Pharmaceutical made up 0.05% of Handelsbanken Fonder's portfolio in Q2 2026, its #293 holding.
  • Handelsbanken Fonder first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Handelsbanken Fonder's West Pharmaceutical position peaked at $19.3M in Q2 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.